Table 2.

SARS-CoV-2 and COVID-19 epidemiology in studied cohort, comparison to the entire diabetes mellitus type 2 population.

Outcomes	PDMC (N = 14,485)	DM2 (N = 231,796 )	P
SARS-CoV-2 positivity, N (%)	2221 (15.3%)	33,741 (14.6%)	0.01
COVID-19 hospitalizations, N (%)	1136 (7.8%)	10,191 (4.4%)	< 0.001
COVID-19 deaths, N (%)	370 (2.6%)	2692 (1.2%)	< 0.001

2-year cumulative incidence presented (years 2020 and 2021);

P values calculated via hi square test;

PDMC Patients with diabetes mellitus type 2 and cardiomyopathy, DM2 Entire diabetes mellitus type 2 population.